Potentiation of the anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the kinase inhibitor Staurosporine or its clinically relevant analogue UCN-01

Dao Nguyen(National Institutes of Health)
British Journal of Cancer
May 1, 2006
Cited by 41


Related Papers